| Literature DB >> 28496442 |
Baozhen Sun1, Zhi Wang1, Ziyan Wang1, Xiongchao Ma1, Fei Zhu1.
Abstract
In this study, we investigated the hemocytes' immune response to white spot syndrome virus (WSSV) or Vibrio alginolyticus infection at the protein level. The differential proteomes from crab hemocytes infected with WSSV or V. alginolyticus were analyzed using the isobaric tags for relative and absolute quantitation approach immediately after infection. Using this approach, we identified 1,799 proteins by their by LC-MS/MS spectra and sequencing data. These included 157 upregulated proteins and 164 downregulated proteins after WSSV infection. Similarly, 243 proteins were determined to be differentially expressed during V. alginolyticus infection, of these, 121 were upregulated and 122 were downregulated after infection. Interestingly, among these differentially expressed proteins, 106 were up- or downregulated significantly in both WSSV and V. alginolyticus infection. Six genes, β-actin, myosin-9, anti-lipopolysaccharide factor isoform 4, anti-lipopolysaccharide factor 4, transketolase-like protein 2-like isoform 1, and sarcoplasmic calcium-binding protein 1 were chosen for further study. The expression of these genes all showed a trend of upregulation at 24 h post-WSSV or V. alginolyticus infection except for myosin-9 in response to WSSV. To confirm the protective effects of the six genes, crabs were injected with specific dsRNAs before WSSV or V. alginolyticus challenge. The results showed that the knockdown of these genes led to an increase in the morbidity and mortality (P < 0.01) rate, and a decrease in infection time in WSSV-infected crabs. During the first 84 h, knockdown of these genes also led to an increase in the morbidity rates in V. alginolyticus -infected crabs, and results of four genes showed a higher mortality rate than that of the control after they were knocked down. This is the first report of the proteome response in crab hemocytes during WSSV or V. alginolyticus infection. These findings will contribute to our understanding of the immune response to WSSV and V. alginolyticus infection in crabs.Entities:
Keywords: Scylla paramamosain; Vibrio alginolyticus; hemocyte; isobaric tags for relative and absolute quantitation; proteomic; white spot syndrome virus
Year: 2017 PMID: 28496442 PMCID: PMC5406513 DOI: 10.3389/fimmu.2017.00468
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Figure 1The basic information and statistics for the isobaric tags for relative and absolute quantitation analysis of . (A) Coverage of proteins by the identified peptides. (B) Distribution of identified proteins among different molecular weights (in kilodaltons). (C) Distribution of proteins containing different number of identified peptides.
Figure 2Gene ontology analysis of proteins in hemocytes of healthy crabs based on cellular component (A), biological process (B), molecular function (C), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway classification (D) of proteins in the hemocytes of healthy crabs.
Figure 3The differentially expressed proteins were evaluated by isobaric tags for relative and absolute quantitation analysis. The numbers represent the proteins that were upregulated or downregulated (more than 1.2-fold) compared with the control or Vibrio alginolyticus group (A). Venn diagram of differentially expressed genes (B). The numbers represented the proteins upregulated or downregulated (more than 1.2-fold) compared with the control. The statistics of gene ontology enrichment of the 106 proteins up- or downregulated significantly in white spot syndrome virus (WSSV) and V. alginolyticus infection (C).
The differential expressed proteins in .
| Protein name | Accession | Score | Coverage | Peptide | Fold change |
|---|---|---|---|---|---|
| Copine-8 | comp20718_c0_seq2_No.1 | 841 | 30.9 | 14 | 6.29 |
| Troponin C isoform 2b | comp22592_c0_seq1_No.1 | 69 | 26.3 | 3 | 5.35 |
| Sarcoplasmic calcium-binding protein 1 | comp40442_c0_seq1_No.1 | 83 | 16.1 | 3 | 4.78 |
| β-Actin | comp12583_c0_seq1_No.1 | 1,377 | 67.2 | 4 | 4.02 |
| Myosin light chain 2 | comp21132_c0_seq1_No.1 | 765 | 34.1 | 9 | 3.58 |
| Slow muscle myosin S1 heavy chain | comp20546_c0_seq16_No.1 | 2,058 | 43.7 | 26 | 2.69 |
| clathrin light chain | comp17823_c1_seq1_No.1 | 147 | 22.5 | 4 | 2.67 |
| Ubiquitin carboxyl-terminal esterase L3 | comp16837_c1_seq1_No.1 | 396 | 31.6 | 6 | 2.65 |
| 2-Phospho- | comp20783_c0_seq1_No.1 | 1,685 | 50.7 | 18 | 2.65 |
| Membrane-associated protein | comp51893_c0_seq1_No.1 | 281 | 15.4 | 2 | 2.64 |
| Alpha actin | comp12775_c1_seq1_No.1 | 1,274 | 57 | 5 | 2.56 |
| Spermatogonial stem-cell renewal factor | comp72221_c0_seq1_No.1 | 240 | 41.9 | 9 | 2.48 |
| Inorganic pyrophosphatase-like protein | comp12817_c0_seq1_No.1 | 216 | 25.3 | 5 | 2.44 |
| Putative phosphoglycerate kinase | comp12041_c0_seq1_No.1 | 897 | 33.5 | 13 | 2.4 |
| Protein kinase c | comp18689_c0_seq1_No.1 | 185 | 13.4 | 8 | 2.36 |
| Glutathione | comp15053_c0_seq1_No.1 | 1,634 | 50.5 | 10 | 2.19 |
| Myosin-9 | comp12936_c0_seq1_No.1 | 382 | 18.3 | 13 | 2.1 |
| Myosin heavy chain type 1 | comp20546_c0_seq7_No.1 | 186 | 38.8 | 2 | 2.04 |
| Sacsin | comp19443_c0_seq1_No.1 | 42 | 0.2 | 1 | 8.76 |
| Pacifastin-like serine protease inhibitor | comp3991_c0_seq1_No.1 | 82 | 15.1 | 2 | 5.45 |
| Male reproductive tract-specific Kazal-type proteinase inhibitor | comp19421_c0_seq1_No.1 | 164 | 11.7 | 1 | 3.77 |
| comp20408_c0_seq1_No.1 | 54 | 7.6 | 1 | 3.1 | |
| Anti-lipopolysaccharide factor isoform 5 | comp12264_c0_seq1_No.1 | 179 | 27.6 | 2 | 2.59 |
| Putative protein phosphatase | comp18826_c0_seq1_No.1 | 117 | 16.4 | 2 | 2.52 |
| Crustin antimicrobial peptide | comp12292_c0_seq1_No.1 | 462 | 35 | 2 | 2.47 |
| Glutathione-dependent prostaglandin D synthase | comp16103_c0_seq1_No.1 | 133 | 25.1 | 5 | 2.42 |
| Cuticular protein analogous to peritrophins 3 | comp12594_c0_seq1_No.1 | 147 | 9.3 | 2 | 2.4 |
| 60S acidic ribosomal protein P2-like protein | comp21230_c0_seq1_No.1 | 292 | 66.7 | 5 | 2.2 |
| Glutathione peroxidase 6 precursor | comp10211_c0_seq1_No.1 | 157 | 17.7 | 4 | 2.18 |
| Chain A, crystal structure of Chmp4b hairpin | comp21559_c0_seq1_No.1 | 356 | 35.3 | 5 | 2.15 |
| Calreticulin precursor | comp14413_c0_seq1_No.1 | 194 | 15.8 | 6 | 2.12 |
| RIKEN | comp2503_c0_seq1_No.1 | 47 | 11.3 | 2 | 2.08 |
| Lactate dehydrogenase | comp19912_c0_seq3_No.1 | 87 | 16.9 | 5 | 2.03 |
| Heat shock protein 90 | comp10311_c0_seq1_No.1 | 332 | 18.5 | 12 | 2 |
The selected proteins in .
| Protein name | Accession | Score | Coverage | Peptide | Fold change | |
|---|---|---|---|---|---|---|
| White spot syndrome virus | VA | |||||
| β-Actin | comp12583_c0_seq1_No.1 | 1,377 | 67.2 | 4 | +4.02 | –1.23 |
| Myosin-9 | comp12936_c0_seq1_No.1 | 382 | 18.3 | 13 | +2.11 | +1.96 |
| Anti-lipopolysaccharide factor 4 | comp12264_c0_seq1_No.1 | 179 | 27.6 | 2 | –2.59 | –2.82 |
| Anti-lipopolysaccharide factor isoform 4 | comp20686_c1_seq1_No.1 | 126 | 47.7 | 4 | –1.86 | –2.12 |
| Transketolase-like protein 2-like isoform 1 | comp18784_c0_seq2_No.1 | 3,418 | 44.3 | 21 | –2.19 | –2.2 |
| Sarcoplasmic calcium-binding protein 1 | comp40442_c0_seq1_No.1 | 83 | 16.1 | 3 | +4.78 | +8.4 |
Figure 4The molecular function (A) statistics of pathway enrichment (B) of differential expressed proteins (more than 1.2-fold) from white spot syndrome virus group vs control group.
Figure 5The molecular function (A) statistics for pathway enrichment (B) of differentially expressed proteins (more than 1.2-fold) from .
The differential expressed proteins in .
| Protein name | Accession | Score | Coverage | Peptide | Fold change |
|---|---|---|---|---|---|
| Sarcoplasmic calcium-binding protein 1 | comp40442_c0_seq1_No.1 | 83 | 16.1 | 3 | 8.40 |
| Troponin C isoform 2b | comp22592_c0_seq1_No.1 | 69 | 26.3 | 3 | 2.78 |
| Clip domain serine proteinase 3 | comp19522_c0_seq1_No.1 | 520 | 33.8 | 9 | 2.40 |
| Copine-8 | comp20718_c0_seq2_No.1 | 841 | 30.9 | 14 | 2.19 |
| Slow muscle myosin S1 heavy chain | comp20546_c0_seq16_No.1 | 2,058 | 43.7 | 26 | 2.13 |
| Putative secreted salivary gland peptide | comp12272_c1_seq1_No.1 | 83 | 22 | 3 | 2.23 |
| Chloride intracellular Channel isoform 1 | comp20820_c0_seq1_No.1 | 100 | 25.7 | 5 | 2.11 |
| Myophilin | comp18304_c1_seq2_No.1 | 1,662 | 62.4 | 8 | 2.03 |
| Spermine synthase | comp18763_c0_seq1_No.1 | 200 | 16.1 | 4 | 2.02 |
| Putative phosphoglycerate kinase | comp12041_c0_seq1_No.1 | 897 | 33.5 | 13 | 2.02 |
| Sacsin | comp19443_c0_seq1_No.1 | 42 | 0.2 | 1 | 31.39 |
| Phospholipase D1 | comp1157_c0_seq1_No.1 | 211 | 17.4 | 5 | 6.97 |
| Low-density lipoprotein receptor | comp20609_c0_seq1_No.1 | 283 | 10.2 | 6 | 5.77 |
| comp20408_c0_seq1_No.1 | 54 | 7.6 | 1 | 3.02 | |
| pacifastin-like serine protease inhibitor | comp3991_c0_seq1_No.1 | 82 | 15.1 | 2 | 2.99 |
| Anti-lipopolysaccharide factor 4 | comp12264_c0_seq1_No.1 | 179 | 27.6 | 2 | 2.82 |
| Anti-lipopolysaccharide factor isoform 4 | comp20686_c1_seq1_No.1 | 126 | 47.7 | 4 | 2.12 |
Figure 6The expression of the selected genes in . Data are shown as means ± SD of three separate individuals in the tissues. Capital letters indicate expression of crustin-like different adult tissues. Double asterisks indicate a significant difference (P < 0.01) between two samples. ALF 4, anti-lipopolysaccharide factor 4; ALF iso4, anti-lipopolysaccharide factor isoform 4; myosin-9, myosin; TLP, transketolase-like protein 2-like isoform 1; SCP, sarcoplasmic calcium-binding protein 1.
Figure 7Comparison of protective effects between six selected genes. The percentage survival of challenged crabs treated with dsRNA. Juvenile Scylla paramamosain were injected intramuscularly with dsRNAs 24 h before white spot syndrome virus (WSSV) challenge (A) or Vibrio alginolyticus challenge (B). Control group was injected with phosphate-buffered saline (PBS) solution, and WSSV or V. alginolyticus group was challenged by WSSV or V. alginolyticus. The treatment is shown on the right. The P-value is the data of experimental groups compared to that of WSSV or V. alginolyticus group.